| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 933.39 KB | Adobe PDF |
Authors
Abstract(s)
Introdução: A ansiedade e a depressão constituem os estados emocionais mais
frequentemente alterados após Lesão Cerebral Adquirida (LCA). Estas alterações
emocionais podem influenciar a motivação e, consequentemente, serem determinantes no
progresso de reabilitação e na qualidade de vida destes indivíduos. Identificar fatores que
possam estar associados à sintomatologia ansiosa e à depressiva poderá auxiliar na
precisão aquando da deteção destes sintomas. Assim, o presente estudo tem como
principal objetivo identificar fatores sociodemográficos, clínicos e de qualidade de vida
associados à sintomatologia ansiosa e sintomatologia depressiva numa população vítima
de LCA em contexto de reabilitação neuropsicológica.
Metodologia: Trata-se de um estudo correlacional numa amostra de 34 participantes
com LCA e que se encontram em contexto de reabilitação neuropsicológica. Para a
recolha de dados, foram utilizados um questionário sociodemográfico, o Montreal
Cognitive Assessment (MoCA) na avaliação das funções cognitivas, o The World Health
Organization Quality of Life (WHOQOL-BREF) na avaliação da qualidade de vida, a The
Work and Social Adjustment Scale (WSAS) na avaliação das capacidades funcionais, o
Clinical Outcome in Routine Evaluation (CORE-10) na avaliação da saúde mental global,
e a Hospital Anxiety and Depression Scale (HADS) na avaliação de sintomas ansiosos e de
sintomas depressivos clinicamente significativos. Procedeu-se à análise descritiva dos dados,
e da relação (associação e regressão) entre variáveis.
Resultados: Segundo os resultados obtidos, 55.9% (n = 19) da amostra apresentaram
sintomatologia ansiosa, 52.9% (n = 18) apresentaram sintomatologia depressiva e 41.2%
(n = 14) apresentaram comorbilidade de sintomas ansiosos e depressivos. Os dados
sugerem que a probabilidade de indivíduos com LCA desenvolverem sintomas ansiosos
aumenta com a gravidade das alterações da saúde mental global e que a probabilidade de
desenvolverem sintomas depressivos é superior nas mulheres e cuja perceção da
qualidade de vida no domínio psicológico é mais baixa. A ocorrência de comorbilidade
de sintomas é mais provável em mulheres com alterações da saúde mental global e cuja
perceção da qualidade de vida no domínio psicológico é mais baixa.
Conclusão: O reconhecimento das dimensões sociodemográficas, clínicas e de
qualidade de vida na deteção de alterações emocionais após LCA é fundamental, pois
pode ser determinante na identificação de fatores que contribuem para o desenvolvimento
de sintomas ansiosos e sintomas depressivos.
Introduction: Anxiety and depression are the emotional states most frequently altered after Acquired Brain Injury (ABI). These emotional changes can influence motivation and, consequently, be decisive in the progress of rehabilitation and in the quality of life of these individuals. Identifying factors that may be associated with anxious and depressive symptoms may assist in the accuracy when detecting these symptoms. Thus, the present study has as main objective to identify sociodemographic, clinical, and quality of life factors associated with anxiety symptoms and depressive symptoms in an ABI victim population in the context of neuropsychological rehabilitation. Methodology: This is a correlational study in a sample of 34 participants with ABI who are in the context of neuropsychological rehabilitation. For data collection, a sociodemographic questionnaire, the Montreal Cognitive Assessment (MoCA) was used to assess cognitive functions, The World Health Organization Quality of Life (WHOQOL-BREF) to assess quality of life, The Work and Social Adjustment Scale (WSAS) in the assessment of functional capabilities, the Clinical Outcome in Routine Evaluation (CORE-10) in the assessment of global mental health, and the Hospital Anxiety and Depression Scale (HADS) in the assessment of anxious and depressive symptoms clinically significant. Descriptive analysis of the data and the relationship (association and regression) between variables was carried out. Results: According to the results obtained, 55.9% (n = 19) of the sample had anxious symptoms, 52.9% (n = 18) had depressive symptoms and 41.2% (n = 14) had anxiety and depressive symptoms. The data suggest that the probability of individuals with ABI to develop anxiety symptoms increases with the severity of changes in global mental health and that the probability of developing depressive symptoms is higher in women and whose perception of quality of life in the psychological domain is lower. The occurrence of symptom comorbidity is more likely in women with changes in global mental health and whose perception of quality of life in the psychological domain is lower. Conclusion: The recognition of the sociodemographic, clinical, and quality of life dimensions in detecting emotional changes after ABI is essential, as it can be decisive in identifying factors that contribute to the development of anxiety symptoms and depressive symptoms.
Introduction: Anxiety and depression are the emotional states most frequently altered after Acquired Brain Injury (ABI). These emotional changes can influence motivation and, consequently, be decisive in the progress of rehabilitation and in the quality of life of these individuals. Identifying factors that may be associated with anxious and depressive symptoms may assist in the accuracy when detecting these symptoms. Thus, the present study has as main objective to identify sociodemographic, clinical, and quality of life factors associated with anxiety symptoms and depressive symptoms in an ABI victim population in the context of neuropsychological rehabilitation. Methodology: This is a correlational study in a sample of 34 participants with ABI who are in the context of neuropsychological rehabilitation. For data collection, a sociodemographic questionnaire, the Montreal Cognitive Assessment (MoCA) was used to assess cognitive functions, The World Health Organization Quality of Life (WHOQOL-BREF) to assess quality of life, The Work and Social Adjustment Scale (WSAS) in the assessment of functional capabilities, the Clinical Outcome in Routine Evaluation (CORE-10) in the assessment of global mental health, and the Hospital Anxiety and Depression Scale (HADS) in the assessment of anxious and depressive symptoms clinically significant. Descriptive analysis of the data and the relationship (association and regression) between variables was carried out. Results: According to the results obtained, 55.9% (n = 19) of the sample had anxious symptoms, 52.9% (n = 18) had depressive symptoms and 41.2% (n = 14) had anxiety and depressive symptoms. The data suggest that the probability of individuals with ABI to develop anxiety symptoms increases with the severity of changes in global mental health and that the probability of developing depressive symptoms is higher in women and whose perception of quality of life in the psychological domain is lower. The occurrence of symptom comorbidity is more likely in women with changes in global mental health and whose perception of quality of life in the psychological domain is lower. Conclusion: The recognition of the sociodemographic, clinical, and quality of life dimensions in detecting emotional changes after ABI is essential, as it can be decisive in identifying factors that contribute to the development of anxiety symptoms and depressive symptoms.
Description
Keywords
Ansiedade Depressão Lesão Cerebral Adquirida Reabilitação Anxiety Depression Acquired Brain Injury Rehabilitation